The Egyptian and Al -Famabiya drugs are discussing the activation of the Memorandum of Understanding and the implementation of the continental organizational cooperation mechanism
Dr. Osama Hatem, Associate Chairman of the Egyptian Medicine Authority for International Policy and Cooperation, and the supervisor of the Central Administration for Drug Policy and Markets Support, on behalf of Dr. Ali Al -Ghamrawi, Chairman of the Egyptian Pharmaceutical Authority, participated in the activities of the official meeting to follow up on the mechanism of activating the memorandum of understanding signed between the Egyptian Pharmaceutical Authority and its Zamra Zamra counterpart, to discuss promoting the joint continental role in building strong drug regulations based on Transparency and competence.
& nbsp; Hatem about his appreciation for constructive cooperation between the two sides, stressing that the meeting represents a practical step towards implementing a common vision based on confidence and integration, noting that activating the memorandum of understanding is not just an executive procedure but rather a start towards a long -term strategic partnership that enhances Egypt’s position as a major supporter of the development of drug regulatory systems on the continent, and contributes to expanding the enforcement of Egyptian products to African markets, especially in light of Regionally growing health challenges. The pharmaceutical industry, the exchange of organizational expertise, and the support of drug security initiatives in Africa, confirming the embassy’s readiness to provide all aspects of support to continue coordination and integration between the two bodies. Africa to keep pace with the increasing health challenges, pointing out his aspiration to translate this cooperation into tangible executive steps on the ground. Others.
& nbsp; Hanan Amine, President of the Central Administration for Pharmaceutical Products, Dr. Asma Fouad, President of the Central Administration for Circular and Creative Conservatives and Clinical Studies. Humanitors, Dr. Umniah Abdullah, Director General of the General Administration for Inspection on Factories, and Dr. Maryam Atef, Director of the Administration and Follow -up of Export Support and Follow -up. Executive of the Export Council for Capital Industries, and representatives of a number of Egyptian companies such as Holding, IPICO and Adeerima.
& nbsp; African drugs affiliated with the African Union Agency, Dr. Niasbi Liuko, Director of the Registration Department of the Zambian Authority, and Dr. Don Sandy Mwangana, Pharmaceutical Inspection Officer of the Zambian Authority, as well as Mr. Mohamed Abdel Fattah, Vice President of the Egyptian Commercial Mission. Contributes to the consolidation of a joint African model of drug regulation dependent on integration and innovation. It also embodies the commitment of the two sides to achieve the goals of the African Union in reaching a comprehensive drug security, localizing the industry, and facilitating the movement of preparations between African markets, in order to enhance the continent’s ability to address health challenges and achieve the well -being of its people.
- For more: Elrisala website and for social networking, you can follow us on Facebook
- Source of information and images “rosaelyoussef”“
